Spirobarbital
Spirobarbital is a barbiturate derivative that was first synthesized in the 1920s. It is a sedative and hypnotic drug that was primarily used in the treatment of insomnia and as a pre-anesthetic. However, its use has been largely discontinued due to the development of safer alternatives and the high risk of addiction associated with barbiturates.
History[edit | edit source]
Spirobarbital was first synthesized in the 1920s, during a period of intense research into barbiturate derivatives. It was one of many new compounds developed in an attempt to find drugs with improved therapeutic profiles and fewer side effects. However, like many other barbiturates, spirobarbital was found to have a high risk of addiction and was eventually superseded by safer alternatives.
Pharmacology[edit | edit source]
As a barbiturate, spirobarbital acts as a central nervous system depressant, producing effects ranging from mild sedation to complete anesthesia. It works by enhancing the action of the neurotransmitter gamma-aminobutyric acid (GABA) at the GABA_A receptor, leading to an increase in inhibitory effects on the central nervous system.
Medical uses[edit | edit source]
Spirobarbital was primarily used as a sedative and hypnotic, for the treatment of insomnia and as a pre-anesthetic. However, its use in these applications has been largely discontinued due to the development of safer alternatives.
Side effects and risks[edit | edit source]
The side effects of spirobarbital are similar to those of other barbiturates and can include drowsiness, confusion, and impaired coordination. More serious side effects can include respiratory depression, coma, and death, particularly in cases of overdose or when combined with other central nervous system depressants.
One of the major risks associated with spirobarbital, as with other barbiturates, is the high potential for addiction. Chronic use can lead to physical dependence and withdrawal symptoms upon cessation of use.
See also[edit | edit source]
| Spirobarbital Resources | |
|---|---|
|
 |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
